Lehmann FS - Search Results

1

Role of pantoprazole in the treatment of gastro-oesophageal reflux disease.

Lehmann FS, Beglinger C. Lehmann FS, et al. Expert Opin Pharmacother. 2005 Jan;6(1):93-104. doi: 10.1517/14656566.6.1.93. Expert Opin Pharmacother. 2005. PMID: 15709887 Review.

2

The role and utility of faecal markers in inflammatory bowel disease.

Lehmann FS, Burri E, Beglinger C. Lehmann FS, et al. Therap Adv Gastroenterol. 2015 Jan;8(1):23-36. doi: 10.1177/1756283X14553384. Therap Adv Gastroenterol. 2015. PMID: 25553077 Free PMC article. Review.

3

Effect of ornidazole and clarithromycin resistance on eradication of Helicobacter pylori in peptic ulcer disease.

Lehmann FS, Drewe J, Terracciano L, Beglinger C. Lehmann FS, et al. Aliment Pharmacol Ther. 2000 Mar;14(3):305-9. doi: 10.1046/j.1365-2036.2000.00717.x. Aliment Pharmacol Ther. 2000. PMID: 10735923 Clinical Trial.

4

[Present position in the prevention and therapy of NSAID-induced ulcers].

Lehmann FS, Beglinger C. Lehmann FS, et al. Schweiz Med Wochenschr. 1999 Jul 27;129(29-30):1073-80. Schweiz Med Wochenschr. 1999. PMID: 10464910 Review. German.

5

Regulation of gastric function by endogenous gastrin releasing peptide in humans: studies with a specific gastrin releasing peptide receptor antagonist.

Hildebrand P, Lehmann FS, Ketterer S, Christ AD, Stingelin T, Beltinger J, Gibbons AH, Coy DH, Calam J, Larsen F, Beglinger C. Hildebrand P, et al. Among authors: lehmann fs. Gut. 2001 Jul;49(1):23-8. doi: 10.1136/gut.49.1.23. Gut. 2001. PMID: 11413106 Free PMC article. Clinical Trial.

6

New molecular targets for treatment of peptic ulcer disease.

Lehmann F, Hildebrand P, Beglinger C. Lehmann F, et al. Drugs. 2003;63(17):1785-97. doi: 10.2165/00003495-200363170-00002. Drugs. 2003. PMID: 12921485 Review.

7

[Gastrin and its role in the development of ulcer disease].

Lehmann FS. Lehmann FS. Schweiz Med Wochenschr. 1997 Apr 5;127(14):579-84. Schweiz Med Wochenschr. 1997. PMID: 9198884 Review. German.

8

Monitoring of therapy for inflammatory bowel disease.

Burri E, Beglinger C, Lehmann FS. Burri E, et al. Among authors: lehmann fs. Digestion. 2012;86 Suppl 1:1-5. doi: 10.1159/000341953. Epub 2012 Oct 5. Digestion. 2012. PMID: 23051719 Review.

9

Impact of COX-2 inhibitors in common clinical practice a gastroenterologist's perspective.

Lehmann FS, Beglinger C. Lehmann FS, et al. Curr Top Med Chem. 2005;5(5):449-64. doi: 10.2174/1568026054201703. Curr Top Med Chem. 2005. PMID: 15974940 Review.

10

Current role of Helicobacter pylori stool tests.

Lehmann FS, Beglinger C. Lehmann FS, et al. Digestion. 2003;68(2-3):119-23. doi: 10.1159/000074682. Epub 2003 Nov 7. Digestion. 2003. PMID: 14610344 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results